(Q48281323)

English

Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model

scientific article published on 5 February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

1 reference

based on heuristic

inferred from title

Jarogniew Łuszczki

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

Marta Andres-Mach

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

Stanisław Jerzy Czuczwar

5

object named as

Stanislaw J Czuczwar

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

Neville Ratnaraj

3

object named as

Neville Ratnaraj

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

author name string

Philip N Patsalos

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

publication date

5 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

48

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

806-815

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

Pharmacokinetics of felbamate in pediatric and adult beagle dogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam monotherapy for newly diagnosed epilepsy patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam monotherapy for elderly patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam monotherapy for adults with localization-related epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Revisiting the concept of identifiable neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam: Relative Bioavailability and Bioequivalence of a 10% Oral Solution (750 mg) and 750‐mg Tablets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam treatment of idiopathic generalised epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam as add-on therapy in generalised epilepsies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Selective blockade of N-type calcium channels by levetiracetam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Clinical pharmacokinetics of levetiracetam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

A neuropharmacological evaluation of felbamate as a novel anticonvulsant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

In Situ Metabolism of Levetiracetam in Blood of Patients with Epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00964.X

21 January 2018

Identifiers

10.1111/J.1528-1167.2006.00964.X

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17284299

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48281323&oldid=2193995826"